Article
Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion
Bullish
65.0
−100 Bearish
0
+100 Bullish
Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Bullish
65.0
−100Neutral+100
More Like This